- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Patenting Synthetic Biology: A Transatlantic Perspective
EU & US | Posted on November 25th, 2009
Investments in synthetic biology research have been ramping up and the field holds significant promise across areas ranging from medicine to renewable energy. As synthetic biology moves forward, it is critical for researchers, technology developers, investors, and public policy makers to understand how the European Patent Office and the U.S. Patent and Trademark Office will react and respond to the applications covering synthetic biology inventions.
This is a unique opportunity to discuss factors influencing EU and U.S. policies on the evolution of intellectual property protection for synthetic biology with experts from both sides of the Atlantic.
You must register to attend this event
Visit www.synbioproject.org to RSVP
***Webcast LIVE at www.synbioproject.org*** No RSVP required for webcast
To learn more about the Synthetic Biology Project, visit www.synbioproject.org.
For more information, please click here
Media planning to cover the event should contact Danielle Altman at (202) 691-4320 or at
Copyright © Woodrow Wilson International Center for ScholarsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015